Jeremy P. Springhorn Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jeremy P. Springhorn.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jeremy P. Springhorn. Jeremy P. Springhorn is Chief Business Officer in Syros Pharmaceuticals, Inc. ($SYRS) and Director in uniQure N.V. ($QURE).
Latest Insider Trading Transactions of Jeremy P. Springhorn
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 04 2021 | QURE | uniQure N.V. | Springhorn Jeremy P. | Director | Sell | S | 37.50 | 505 | 18,938 | 9,945 | 10.5 K to 9.9 K (-4.83 %) |
| Mar 01 2021 | QURE | uniQure N.V. | Springhorn Jeremy P. | Director | Option Exercise | A | 37.00 | 4,107 | 151,959 | 4,107 | |
| Mar 01 2021 | QURE | uniQure N.V. | Springhorn Jeremy P. | Director | Grant | A | 0.00 | 2,382 | 0 | 10,450 | 8.1 K to 10.5 K (+29.52 %) |
| Feb 19 2021 | SYRS | Syros Pharmaceutic ... | Springhorn Jeremy P. | Chief Business Offi ... | Option Exercise | A | 11.41 | 94,000 | 1,072,540 | 94,000 | |
| Mar 02 2020 | QURE | uniQure N.V. | Springhorn Jeremy P. | Director | Option Exercise | A | 51.81 | 3,620 | 187,552 | 3,620 | |
| Mar 02 2020 | QURE | uniQure N.V. | Springhorn Jeremy P. | Director | Grant | A | 0.00 | 2,063 | 0 | 8,068 | 6 K to 8.1 K (+34.35 %) |
| Feb 14 2020 | SYRS | Syros Pharmaceutic ... | Springhorn Jeremy P. | Chief Business Offi ... | Option Exercise | A | 7.54 | 94,000 | 708,760 | 94,000 | |
| Jan 30 2020 | QURE | uniQure N.V. | Springhorn Jeremy P. | Director | Sell | S | 62.20 | 803 | 49,947 | 6,005 | 6.8 K to 6 K (-11.79 %) |
| Jan 30 2020 | QURE | uniQure N.V. | Springhorn Jeremy P. | Director | Sell | S | 60.94 | 4 | 244 | 6,808 | 6.8 K to 6.8 K (-0.06 %) |
| Jan 30 2019 | QURE | uniQure N.V. | Springhorn Jeremy P. | Director | Sell | S | 31.32 | 1,210 | 37,897 | 6,812 | 8 K to 6.8 K (-15.08 %) |
| Jan 29 2019 | QURE | uniQure N.V. | Springhorn Jeremy P. | Director | Option Exercise | A | 31.71 | 5,295 | 167,904 | 5,295 | |
| Jan 29 2019 | QURE | uniQure N.V. | Springhorn Jeremy P. | Director | Grant | A | 0.00 | 3,230 | 0 | 8,022 | 4.8 K to 8 K (+67.40 %) |
| Jan 30 2018 | QURE | uniQure N.V. | Springhorn Jeremy P. | Director | Option Exercise | A | 19.39 | 6,390 | 123,902 | 6,390 | |
| Jan 30 2018 | QURE | uniQure N.V. | Springhorn Jeremy P. | Director | Grant | A | 0.00 | 4,792 | 0 | 4,792 | 0 to 4.8 K |
| Dec 15 2017 | SYRS | Syros Pharmaceutic ... | Springhorn Jeremy P. | Chief Business Offi ... | Buy | P | 9.08 | 15,000 | 136,260 | 15,000 | 0 to 15 K |
| Nov 14 2017 | SYRS | Syros Pharmaceutic ... | Springhorn Jeremy P. | Chief Business Offi ... | Option Exercise | A | 11.65 | 50,000 | 582,500 | 50,000 | |
| Nov 14 2017 | SYRS | Syros Pharmaceutic ... | Springhorn Jeremy P. | Chief Business Offi ... | Option Exercise | A | 11.65 | 150,000 | 1,747,500 | 150,000 | |
| Sep 26 2017 | QURE | uniQure N.V. | Springhorn Jeremy P. | Director | Option Exercise | A | 8.49 | 10,000 | 84,900 | 10,000 |
Page: 1